臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yu c j"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 1596-1620 of 2308 (93 Page(s) Totally)
<< < 59 60 61 62 63 64 65 66 67 68 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-06-17T03:01:28Z	EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs	Lin C.-A.;Sung-Liang Yu;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Yang P.-C.;Ho C.-C.; Lin C.-A.; SUNG-LIANG YU; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; Ho C.-C.
臺大學術典藏	2020-06-01T09:06:40Z	National survey of ABC (A1C, blood pressure, cholesterol) of Diabetes Health Promotion Institutes in Taiwan: 2002–2018	Chih-Yuan Wang;Tu S.-T.;Sheu W.H.-H.;Chen I.-C.;Chuang L.-M.;Wu M.-S.;Yu C.-J.; CHIH-YUAN WANG; Tu S.-T.; Sheu W.H.-H.; Chen I.-C.; Chuang L.-M.; Wu M.-S.; Yu C.-J.
臺大學術典藏	2020-06-01T03:55:43Z	Small cell lung cancer and acromegaly: A case report	Weng S.-F.;Liao K.-M.;Su D.-H.;Yu C.-J.;Fen-Yu Tseng; Weng S.-F.; Liao K.-M.; Su D.-H.; Yu C.-J.; FEN-YU TSENG
臺大學術典藏	2020-06-01T03:55:31Z	Advanced physical examination training course improves medical students' confidence in physical examination	Fen-Yu Tseng;Chang Y.-T.;Yu C.-J.;Chang S.-C.; FEN-YU TSENG; Chang Y.-T.; Yu C.-J.; Chang S.-C.
臺大學術典藏	2020-06-01T03:27:13Z	Performance assessment of the BluePoint MycoID plus kit for identification of Mycobacterium tuberculosis, including rifampin- and isoniazid-resistant isolates, and nontuberculous mycobacteria	Hsueh P.-R.;Yu C.-J.;WEI-YIH CHIU;Chang T.-C.;Chien J.-Y.; Chien J.-Y.; Chang T.-C.; WEI-YIH CHIU; Yu C.-J.; Hsueh P.-R.
臺大學術典藏	2020-05-26T09:27:33Z	High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma	Chih-Hsin Yang;Cheng A.-L;Yeh K.-H;Yu C.-J;Lin J.-F;Yang P.-C.; CHIH-HSIN YANG; Cheng A.-L; Yeh K.-H; Yu C.-J; Lin J.-F; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:29Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	Kuo S.-H;Chih-Hsin Yang;Yu C.-J;Hsu C;Cheng A.-L;Yang P.-C.; Kuo S.-H; CHIH-HSIN YANG; Yu C.-J; Hsu C; Cheng A.-L; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:27Z	Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients	Chang G.-C;Tsai C.-M;Chen K.-C;Yu C.-J;Shih J.-Y;Yang T.-Y;Lin C.-P;Hsu J.-Y;Chiu C.-H;Perng R.-P;Yang P.-C;Chih-Hsin Yang; Chang G.-C; Tsai C.-M; Chen K.-C; Yu C.-J; Shih J.-Y; Yang T.-Y; Lin C.-P; Hsu J.-Y; Chiu C.-H; Perng R.-P; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:27Z	Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer	Shih J.-Y;Gow C.-H;Yu C.-J;Chih-Hsin Yang;Chang Y.-L;Tsai M.-F;Hsu Y.-C;Chen K.-Y;Su W.-P;Yang P.-C.; Shih J.-Y; Gow C.-H; Yu C.-J; CHIH-HSIN YANG; Chang Y.-L; Tsai M.-F; Hsu Y.-C; Chen K.-Y; Su W.-P; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:27Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Hsu C;Yang P.-C.; Su W.-P; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Hsu C; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:26Z	Revisit of 1997 TNM staging system - Survival analysis of 1112 lung cancer patients in Taiwan	Perng R.-P;Chen C.-Y;Chang G.-C;Hsia T.-C;Hsu N.-Y;Tsai Y.-H;Tsai C.-M;Chih-Hsin Yang;Chen Y.-M;Yu C.-J;Lee J.-J;Hsu H.-S;Yu C.-T;Kao E.-L;Chiu C.-H.; Perng R.-P; Chen C.-Y; Chang G.-C; Hsia T.-C; Hsu N.-Y; Tsai Y.-H; Tsai C.-M; CHIH-HSIN YANG; Chen Y.-M; Yu C.-J; Lee J.-J; Hsu H.-S; Yu C.-T; Kao E.-L; Chiu C.-H.
臺大學術典藏	2020-05-26T09:27:26Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Chih-Hsin Yang;Shih J.-Y;Chen K.-C;Yu C.-J;Yang T.-Y;Lin C.-P;Su W.-P;Gow C.-H;Hsu C;Chang G.-C;Yang P.-C.; CHIH-HSIN YANG; Shih J.-Y; Chen K.-C; Yu C.-J; Yang T.-Y; Lin C.-P; Su W.-P; Gow C.-H; Hsu C; Chang G.-C; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:25Z	A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma	Chen Y.-M;Yu C.-J;Chih-Hsin Yang;Perng R.-P;Tsai C.-M;Shih J.-F;Cheng A.-L;Lefresne F;Barbier M;Pouget J.-C;Yang P.-C.; Chen Y.-M; Yu C.-J; CHIH-HSIN YANG; Perng R.-P; Tsai C.-M; Shih J.-F; Cheng A.-L; Lefresne F; Barbier M; Pouget J.-C; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:24Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Kuo S.-H;Chiu Y.-H;Chang Y.-L;Chien C.-R;Gow C.-H; Gow C.-H; Chien C.-R; Chang Y.-L; Chiu Y.-H; Kuo S.-H; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:24Z	MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib	Bean J;Brennan C;Shih J.-Y;Riely G;Viale A;Wang L;Chitale D;Motoi N;Szoke J;Broderick S;Balak M;Chang W.-C;Yu C.-J;Gazdar A;Pass H;Rusch V;Gerald W;Huang S.-F;Yang P.-C;Miller V;Ladanyi M;Chih-Hsin Yang;Pao W.; Bean J; Brennan C; Shih J.-Y; Riely G; Viale A; Wang L; Chitale D; Motoi N; Szoke J; Broderick S; Balak M; Chang W.-C; Yu C.-J; Gazdar A; Pass H; Rusch V; Gerald W; Huang S.-F; Yang P.-C; Miller V; Ladanyi M; CHIH-HSIN YANG; Pao W.
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:23Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chih-Hsin Yang;Shih J.-Y;Hsu C;Yu C.-J;Lo Y;Chen J.-P; Chen J.-P; Lo Y; Yu C.-J; Hsu C; Shih J.-Y; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:22Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Shih J.-Y; Lee Y.-C; Yang P.-C.; Yang P.-C.;Lee Y.-C;Shih J.-Y;Hsu Y.-C;Chih-Hsin Yang;Chang Y.-L;Yu C.-J;Gow C.-H;Wu S.-G; Wu S.-G; Gow C.-H; Yu C.-J; Chang Y.-L; CHIH-HSIN YANG; Hsu Y.-C
臺大學術典藏	2020-05-26T09:27:22Z	High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy	Kao W.-Y.;Lin Z.-Z;Yu C.-T;Kuo H.-P;Chang W.-C;Yu C.-J;Chung C.-Y;Ho M.-L;Wang J.-L;Huang M.-S;Chen C.-H;Chen H.-C;Hsia T.-C;Tsao C.-J;Su W.-C;Lai R.-S;Chu N.-M;Hsieh R.-K;Lin M.-C;Chang G.-C;Chen Y.-M;Chih-Hsin Yang;Perng R.-P; Perng R.-P; CHIH-HSIN YANG; Chen Y.-M; Chang G.-C; Lin M.-C; Hsieh R.-K; Chu N.-M; Lai R.-S; Su W.-C; Tsao C.-J; Hsia T.-C; Chen H.-C; Chen C.-H; Huang M.-S; Wang J.-L; Ho M.-L; Chung C.-Y; Yu C.-J; Chang W.-C; Kuo H.-P; Yu C.-T; Lin Z.-Z; Kao W.-Y.
臺大學術典藏	2020-05-26T09:27:22Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang P.-C.;Pao W;Cheng A.-L;Bean J;Huang C.-L;Shun C.-T;Huang C.-J;Lin Z.-Z;Chen K.-Y;Tsai M.-C;Hu F.-C;Chang Y.-C;Shih J.-Y;Yu C.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Chang Y.-C; Hu F.-C; Tsai M.-C; Chen K.-Y; Lin Z.-Z; Huang C.-J; Shun C.-T; Huang C.-L; Bean J; Cheng A.-L; Pao W; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y.

Showing items 1596-1620 of 2308 (93 Page(s) Totally)
<< < 59 60 61 62 63 64 65 66 67 68 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :2856708
	Visitors : 53592263 Online Users : 803 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library